Free Trial

Oracle (NYSE:ORCL) PT Raised to $205.00 at JMP Securities

Oracle logo with Computer and Technology background

Oracle (NYSE:ORCL - Get Free Report) had its price objective raised by stock analysts at JMP Securities from $175.00 to $205.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a "market outperform" rating on the enterprise software provider's stock. JMP Securities' price objective points to a potential upside of 15.92% from the stock's current price.

Several other equities analysts have also issued reports on the stock. Citigroup lifted their price target on shares of Oracle from $140.00 to $157.00 and gave the stock a "neutral" rating in a report on Wednesday, September 11th. Guggenheim boosted their target price on Oracle from $185.00 to $200.00 and gave the stock a "buy" rating in a research note on Friday, September 13th. UBS Group increased their price target on Oracle from $160.00 to $175.00 and gave the company a "buy" rating in a research note on Tuesday, September 10th. KeyCorp boosted their price target on Oracle from $165.00 to $175.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 10th. Finally, Oppenheimer reaffirmed a "market perform" rating on shares of Oracle in a research report on Tuesday, September 10th. Ten investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $168.67.

Read Our Latest Analysis on Oracle

Oracle Stock Up 0.7 %

ORCL stock traded up $1.16 during trading on Friday, hitting $176.84. 1,664,450 shares of the company's stock traded hands, compared to its average volume of 8,443,326. The firm has a market capitalization of $487.35 billion, a P/E ratio of 47.55, a PEG ratio of 3.29 and a beta of 1.01. Oracle has a 1 year low of $99.26 and a 1 year high of $178.61. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 6.68. The business has a fifty day simple moving average of $155.43 and a two-hundred day simple moving average of $138.15.

Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Monday, September 9th. The enterprise software provider reported $1.39 EPS for the quarter, topping the consensus estimate of $1.33 by $0.06. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The firm had revenue of $13.31 billion during the quarter, compared to analyst estimates of $13.23 billion. During the same period in the previous year, the company posted $0.95 EPS. The business's revenue for the quarter was up 6.9% compared to the same quarter last year. Sell-side analysts anticipate that Oracle will post 5 EPS for the current year.

Insider Transactions at Oracle

In other news, EVP Maria Smith sold 6,320 shares of the business's stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $165.00, for a total transaction of $1,042,800.00. Following the transaction, the executive vice president now owns 42,889 shares of the company's stock, valued at approximately $7,076,685. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 42.80% of the company's stock.

Institutional Investors Weigh In On Oracle

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ORCL. Janus Henderson Group PLC raised its holdings in Oracle by 148.8% in the 1st quarter. Janus Henderson Group PLC now owns 12,872,300 shares of the enterprise software provider's stock valued at $1,616,855,000 after buying an additional 7,699,141 shares during the period. PineStone Asset Management Inc. raised its stake in shares of Oracle by 131.2% in the 2nd quarter. PineStone Asset Management Inc. now owns 3,911,201 shares of the enterprise software provider's stock valued at $552,262,000 after acquiring an additional 2,219,450 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Oracle by 97.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 4,242,647 shares of the enterprise software provider's stock worth $532,920,000 after acquiring an additional 2,093,893 shares during the last quarter. Altshuler Shaham Ltd boosted its position in shares of Oracle by 5,853.1% during the 2nd quarter. Altshuler Shaham Ltd now owns 1,552,580 shares of the enterprise software provider's stock worth $219,224,000 after purchasing an additional 1,526,500 shares during the period. Finally, Vanguard Group Inc. increased its holdings in Oracle by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 151,213,890 shares of the enterprise software provider's stock valued at $18,993,977,000 after purchasing an additional 1,514,569 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company's stock.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Analyst Recommendations for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Elon Musk Drops Stunning Bombshell? (From Paradigm Press) (Ad)

Should you invest $1,000 in Oracle right now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster
Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines